Table 1 Baseline characteristics of patient subjects at the start of DPO CERA treatment
From: Effects of darbepoetin alfa and epoetin beta pegol on iron kinetics in hemodialysis patients
At the time of DPO treatment | At the time of CERA treatment | P value | |
|---|---|---|---|
Hemoglobin (g/dL) | 10.5 ± 0.34 | 10.4 ± 0.75 | 0.799 |
Serum iron (μg/dL) | 82.4 ± 26.34 | 89.3 ± 26.62 | 0.447 |
Serum ferritin (ng/mL) | 160.69 ± 66.84 | 163.67 ± 67.40 | 0.612 |
TSAT (%) | 45.3 ± 17.82 | 39.8 ± 9.44 | 0.311 |
Hepcidin (ng/mL) | 98.9 ± 35.42 | 79.3 ± 27.95 | 0.176 |
hs-CRP (mg/dL) | 0.19 ± 6.81 | 0.07 ± 5.01 | 0.112 |
Albumin (g/dL) | 3.5 ± 0.29 | 3.7 ± 0.22 | 0.106 |
Body weight (kg) | 57.9 ± 5.2 | 58.2 ± 5.0 | 0.229 |
ΔBody weight (kg)a | 0.07 ± 0.45 | 0.30 ± 0.56 | 0.501 |